Epidermology of tb and investigation psm k park detail easy language

Reading File
Finding Sources
Finding Sources
Finding Sources
Reading File
Finding Sources
Reading File
Reading File
Reading File
Finding Sources
Reading File
Reading File
I now have sufficient content from Park's PSM to give a comprehensive, well-organized answer. Let me compile everything.

Tuberculosis (TB) - Epidemiology & Investigations

As per Park's Textbook of Preventive and Social Medicine


1. WHAT IS TB?

TB is a specific infectious disease caused by Mycobacterium tuberculosis. It mainly affects the lungs (pulmonary TB), but can also affect:
  • Intestine
  • Meninges (brain covering)
  • Bones and joints
  • Lymph glands
  • Skin
Bovine TB (from cattle) can also be transmitted to humans.

2. GLOBAL BURDEN (Problem Statement)

FactDetail
Population infected (silent)~1/3rd of world population asymptomatically infected
Who develops disease5-10% of infected develop clinical TB in their lifetime
New cases/year (2019)~10 million globally
Annual infection risk in high burden countries0.5-2%
One patient spreads to10-15 persons per year
TB deaths (HIV-negative, 2019)1.2 million
TB deaths (HIV-positive, 2019)208,000
Gender splitMen 56%, Women 32%, Children <15 yrs 12%

3. INDIA'S TB BURDEN

  • India has the highest TB burden in the world.
  • 2/3 of cases are males, but >50% of female cases occur in those below 34 years of age.
  • TB kills more women in reproductive age than all maternal causes combined.
  • 1/3 of female infertility in India is caused by TB.
  • ~3 lakh children of TB patients drop out of school.
  • A patient loses 3-4 months of income during recuperation.
  • 90% of TB's economic burden = loss of life, not just illness.
  • Mainly a disease of the poor: migrant labourers, slum dwellers, and backward areas.

4. EPIDEMIOLOGICAL INDICES (How We Measure TB in a Community)

These are important Park's PSM exam points:
IndexMeaning
IncidenceNew + recurrent (relapse) TB episodes in a given year
PrevalenceTotal TB cases (all forms) at a given point in time; best index for case load
MortalityDeaths due to TB (HIV-negative counted separately from HIV-positive per ICD-10)
Case Fatality RateRisk of death among those with active TB
Case Notification RateNew + recurrent TB cases notified to WHO per 100,000 population per year
Case Detection RateNotifications of new+relapse cases ÷ Estimated incidence × 100

5. CLASSIFICATION OF TB CASES

A. Based on Drug Susceptibility (Drug Resistance)

TypeDefinition
Mono-resistanceResistant to ONE first-line drug only
Polydrug resistanceResistant to >1 first-line drug (but NOT both INH + Rifampicin together)
MDR-TBResistant to at least BOTH Isoniazid (INH) and Rifampicin
XDR-TBMDR + resistant to any fluoroquinolone + at least one second-line injectable (kanamycin, amikacin, capreomycin)
Rifampicin Resistance (RR-TB)Resistance to Rifampicin by any method (includes MDR + XDR)

B. Based on HIV Status

  • HIV-positive TB
  • HIV-negative TB
  • HIV-unknown TB

6. INVESTIGATIONS FOR TB (Case Finding)

A. Sputum Smear Microscopy (Most Important - Primary Method)

  • Sputum examination by direct microscopy = Method of Choice for field diagnosis
  • Stains used:
    • ZN (Ziehl-Neelsen) stain - conventional microscope
    • LED FM (Fluorescent Microscopy) - more sensitive
  • Why it's #1: Cheap, reliable, easy, discovers the most epidemiologically dangerous cases (sputum-positive = biggest spreaders)
  • Limitation: Limited sensitivity, especially in children and HIV-positive patients

B. Culture

MethodDetail
Solid culture (LJ medium)Gold standard but takes 6-8 weeks
Liquid culture (MGIT-960, BacT Alert, Versatrek)Faster; results in up to 42 days
Drug Sensitivity Testing (DST)Available 14-26 days after culture turns positive
  • Used for:
    • Follow-up of DR-TB patients
    • Long-term follow-up of DS-TB to ensure relapse-free cure

C. Rapid Molecular Tests

TestWhat it detects
CBNAAT / TrueNat (NAAT)MTB + Rifampicin resistance (rpoB gene)
Line Probe Assay (LPA) - FL LPAMTB complex + RIF & INH resistance
Line Probe Assay - SL LPAFluoroquinolone + Second-line injectable resistance
PCR-based methodsrpoB (Rifampicin), katG + inhA (Isoniazid) resistance genes

D. Tuberculin Skin Test (TST / Mantoux Test)

  • Detects cellular immune response to TB proteins (PPD)
  • Read at 48-72 hours after injection
  • Positive = presence of infection (NOT necessarily active disease)
  • Limitations (important for exams):
    • Negative test does NOT rule out TB (immune response may be depressed in active TB)
    • False negatives: HIV, malnutrition, malignancy, Hodgkin's, measles, chickenpox, steroids, severe bacterial infections, BCG recently given
    • False positives: BCG vaccination, atypical mycobacteria cross-reaction
Two-Step Testing (for health workers):
  • 1st test → if negative → 2nd test after 1-3 weeks → if 2nd positive = old infection (boosted), if 2nd negative = truly uninfected

E. Interferon Gamma Release Assay (IGRA)

  • Blood test, more specific than TST
  • Not affected by BCG vaccination
  • Used as supportive diagnostic tool

F. Supportive/Radiological Tools

  • Chest X-ray - shows cavitation, infiltrates, hilar adenopathy (supportive, not confirmatory)
  • Histopathology - caseous granuloma with Langhans giant cells (tissue biopsy)

7. QUICK MEMORY TABLE: Investigations at a Glance

TestUseKey Point
Sputum Smear (ZN stain)Primary case findingCheap, fast, most used
Culture (LJ/MGIT)Confirmation + DSTTakes weeks
CBNAAT/TrueNatRapid diagnosis + Rif resistanceDone in 2 hours
LPA (FL/SL)First/second-line drug resistanceFor MDR/XDR-TB
Mantoux/TSTInfection screenDoes NOT confirm active TB
IGRAInfection screenMore specific than TST
Chest X-raySupportiveNot confirmatory

8. TB PREVENTIVE TREATMENT (2019 Data)

  • 45% of HIV-positive newly enrolled patients received preventive treatment
  • 33% of children under 5 (household contacts of confirmed TB) received preventive treatment

Source: Park's Textbook of Preventive and Social Medicine, 25th edition - Chapter on Tuberculosis (Epidemiology, Investigations, RNTCP/NTEP)

Exam Tips (PSM perspective):
  • Sputum smear = method of choice for case finding in the field
  • Prevalence = best practical index for case load
  • 1/3 of world infected, 5-10% develop disease
  • One infectious patient spreads to 10-15 persons/year
  • MDR = INH + Rifampicin resistance (minimum)
  • Negative Mantoux does NOT rule out TB (immunosuppression causes false negatives)
This is a shared conversation. Sign in to Orris to start your own chat.